alexa Valli De Re | National Cancer Institute
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Valli De Re

Valli De Re Valli De Re
Department of Molecular Oncology &
Translational Medicine
National Cancer Institute 

Dr. Valli De Re is a Faculty from Experimental and Clinical Pharmacology, Department of Molecular Oncology and Translational Medicine (DOMERT),Centro di Riferimento Oncologico, IRCCS, National Cancer Institute, Italy

Research Interest

Lymphoproliferations and cancer associated to inflammation due to chronic autoimmune diseases or virus infection. B and T-cell repertoire, BCR and TCR recognition, MHC molecules. In the last years combine molecular and proteomic approaches for the study of lymphoproliferative disorders associated with Hepatitis C virus infection and with chronic inflammation, identification and production of recombinant protein useful for bio-therapeutic approaches, identification of markers useful for early diagnosis of gastric carcinoma and for celiac disease complications.


Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version